Presima Securities ULC Grows Position in Sabra Healthcare REIT, Inc. $SBRA

Presima Securities ULC increased its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 6.7% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,060,612 shares of the real estate investment trust’s stock after acquiring an additional 66,924 shares during the quarter. Sabra Healthcare REIT comprises about 4.5% of Presima Securities ULC’s investment portfolio, making the stock its 10th largest holding. Presima Securities ULC owned approximately 0.45% of Sabra Healthcare REIT worth $19,558,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. Allspring Global Investments Holdings LLC bought a new position in Sabra Healthcare REIT in the 1st quarter valued at about $298,000. New York State Teachers Retirement System increased its holdings in Sabra Healthcare REIT by 12.1% in the 1st quarter. New York State Teachers Retirement System now owns 321,647 shares of the real estate investment trust’s stock valued at $5,619,000 after buying an additional 34,591 shares during the period. M&T Bank Corp increased its holdings in Sabra Healthcare REIT by 2.1% in the 1st quarter. M&T Bank Corp now owns 51,827 shares of the real estate investment trust’s stock valued at $905,000 after buying an additional 1,059 shares during the period. Cambridge Investment Research Advisors Inc. increased its holdings in Sabra Healthcare REIT by 4.7% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust’s stock valued at $331,000 after buying an additional 853 shares during the period. Finally, Ethos Financial Group LLC bought a new position in Sabra Healthcare REIT in the 1st quarter valued at about $1,150,000. 99.40% of the stock is owned by institutional investors.

Sabra Healthcare REIT Trading Up 2.0%

Shares of Sabra Healthcare REIT stock opened at $17.82 on Friday. The firm has a market capitalization of $4.27 billion, a PE ratio of 23.45, a price-to-earnings-growth ratio of 1.10 and a beta of 0.85. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. The firm’s 50 day moving average is $18.50 and its 200 day moving average is $18.25. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.02. The company had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The firm’s revenue was up 7.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.7%. The ex-dividend date of this dividend was Friday, August 15th. Sabra Healthcare REIT’s payout ratio is presently 157.89%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on SBRA shares. Truist Financial raised their target price on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a “hold” rating in a report on Tuesday, September 2nd. Cantor Fitzgerald initiated coverage on Sabra Healthcare REIT in a research note on Wednesday, October 1st. They set a “neutral” rating and a $20.00 target price for the company. Weiss Ratings reissued a “buy (b)” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, October 8th. National Bankshares set a $22.00 price target on shares of Sabra Healthcare REIT in a report on Friday, October 17th. Finally, BMO Capital Markets lifted their price target on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a “market perform” rating in a report on Monday, August 25th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $20.75.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.